Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.95 Analyst target: $17.00 Upside: 1697.61%
Acurx Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company is headquartered in Staten Island, New York.
See the full interactive analysis & chart →Informational only — not investment advice.